Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Lease of New Jersey manufacturing facilities; rent paid to Kanan
Omalizumab development and commercialization agreement with up-front and milestone payments
Omalizumab agreement: Company expensed developmental milestones
Biologic license and commercialization agreement (Kashiv License Agreement) with potential milestone payments and profit share
Kashiv License Agreement: Company recorded expenses for payments to Kashiv, including royalties and milestones
Company purchased inventory of the two approved Kashiv products
Generic product development and supply agreement; Company recognized reimbursable costs as a reduction to R&D expense
Injectable License and Supply Agreement; Company recorded R&D expense including milestone payment
Carfilzomib License Agreement; Company recorded R&D expense for upfront payment
Storage Agreement under which Company provided storage and inventory transfer services; Kashiv paid the Company
Acquisition of parcels of land in India for construction of peptide manufacturing facilities
Consulting services agreement for clinical studies and regulatory advice; Company recorded expenses
Employment as operational and strategic advisor; total cash compensation
Long-term incentive award granted to Kanubhai Patel
Employment as senior manager in information technology department; total compensation
Employment as manager in engineering department; total compensation
Tax Receivable Agreement under which Members receive payments for tax benefits, amended in connection with the Reorganization
Pledging arrangements between the Company and trusts controlled by Chirag Patel, discussed in the Security Ownership section
Loading...
